Antithrombotic therapy in Atrial Fibrillation & valvular heart disease a joint consensus document from the EHRA and ESC WG on Thrombosis, endorsed by the ESC WG on Valvular Heart Disease, CASSA, HRS, APHRS, SA Heart Association and SOLEACE date_range Publicado el 13 de 11 de 2018 Continue lendo